CN118546878B - A serum-free culture medium for in vitro culture of hemolymphocytes of scallop - Google Patents
A serum-free culture medium for in vitro culture of hemolymphocytes of scallop Download PDFInfo
- Publication number
- CN118546878B CN118546878B CN202411024828.0A CN202411024828A CN118546878B CN 118546878 B CN118546878 B CN 118546878B CN 202411024828 A CN202411024828 A CN 202411024828A CN 118546878 B CN118546878 B CN 118546878B
- Authority
- CN
- China
- Prior art keywords
- serum
- scallop
- culture medium
- culture
- pym
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000338 in vitro Methods 0.000 title claims abstract description 18
- 239000004017 serum-free culture medium Substances 0.000 title claims abstract 5
- 235000020637 scallop Nutrition 0.000 title abstract description 51
- 241000237509 Patinopecten sp. Species 0.000 title abstract description 47
- 239000001963 growth medium Substances 0.000 claims abstract description 52
- 210000004698 lymphocyte Anatomy 0.000 claims abstract description 27
- 241000237516 Mizuhopecten yessoensis Species 0.000 claims abstract description 19
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 14
- -1 salt ions Chemical class 0.000 claims abstract description 10
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000004472 Lysine Substances 0.000 claims abstract description 7
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229960003080 taurine Drugs 0.000 claims abstract description 7
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims abstract description 6
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims abstract description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 16
- 230000003204 osmotic effect Effects 0.000 claims description 13
- 238000012258 culturing Methods 0.000 claims description 9
- 239000011780 sodium chloride Substances 0.000 claims description 8
- 239000003242 anti bacterial agent Substances 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 229940088710 antibiotic agent Drugs 0.000 claims description 6
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 claims description 6
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical group OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 claims description 4
- 239000007995 HEPES buffer Substances 0.000 claims description 4
- 229960002518 gentamicin Drugs 0.000 claims description 4
- 239000006174 pH buffer Substances 0.000 claims description 4
- 229930182555 Penicillin Natural products 0.000 claims description 3
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims description 3
- 229940049954 penicillin Drugs 0.000 claims description 3
- 229960005322 streptomycin Drugs 0.000 claims description 3
- 229930182566 Gentamicin Natural products 0.000 claims description 2
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 claims description 2
- 239000012679 serum free medium Substances 0.000 claims 11
- 239000007836 KH2PO4 Substances 0.000 claims 1
- 230000003115 biocidal effect Effects 0.000 claims 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 claims 1
- 230000012010 growth Effects 0.000 abstract description 8
- 230000004083 survival effect Effects 0.000 abstract description 8
- 239000013553 cell monolayer Substances 0.000 abstract description 5
- 238000011081 inoculation Methods 0.000 abstract description 5
- 210000000601 blood cell Anatomy 0.000 abstract description 3
- 210000004748 cultured cell Anatomy 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 48
- 239000000243 solution Substances 0.000 description 23
- 210000002966 serum Anatomy 0.000 description 22
- 150000001413 amino acids Chemical class 0.000 description 15
- 210000000087 hemolymph Anatomy 0.000 description 14
- 239000002609 medium Substances 0.000 description 9
- 235000015170 shellfish Nutrition 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 7
- 230000021164 cell adhesion Effects 0.000 description 7
- 238000011160 research Methods 0.000 description 7
- 241000237852 Mollusca Species 0.000 description 5
- 239000007640 basal medium Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000035755 proliferation Effects 0.000 description 5
- 241000237503 Pectinidae Species 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- BQRGNLJZBFXNCZ-UHFFFAOYSA-N calcein am Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(CN(CC(=O)OCOC(C)=O)CC(=O)OCOC(C)=O)=C(OC(C)=O)C=C1OC1=C2C=C(CN(CC(=O)OCOC(C)=O)CC(=O)OCOC(=O)C)C(OC(C)=O)=C1 BQRGNLJZBFXNCZ-UHFFFAOYSA-N 0.000 description 4
- 238000004113 cell culture Methods 0.000 description 4
- 239000006143 cell culture medium Substances 0.000 description 4
- 238000010186 staining Methods 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 241000237536 Mytilus edulis Species 0.000 description 3
- 239000003146 anticoagulant agent Substances 0.000 description 3
- 229940127219 anticoagulant drug Drugs 0.000 description 3
- 230000010261 cell growth Effects 0.000 description 3
- 230000004663 cell proliferation Effects 0.000 description 3
- 239000012091 fetal bovine serum Substances 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 235000020638 mussel Nutrition 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- INAAIJLSXJJHOZ-UHFFFAOYSA-N pibenzimol Chemical compound C1CN(C)CCN1C1=CC=C(N=C(N2)C=3C=C4NC(=NC4=CC=3)C=3C=CC(O)=CC=3)C2=C1 INAAIJLSXJJHOZ-UHFFFAOYSA-N 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000011550 stock solution Substances 0.000 description 3
- 210000003699 striated muscle Anatomy 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 239000012224 working solution Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 238000012165 high-throughput sequencing Methods 0.000 description 2
- 238000012606 in vitro cell culture Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000036456 mitotic arrest Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 230000008844 regulatory mechanism Effects 0.000 description 2
- 239000013535 sea water Substances 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- WXHLLJAMBQLULT-UHFFFAOYSA-N 2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-n-(2-methyl-6-sulfanylphenyl)-1,3-thiazole-5-carboxamide;hydrate Chemical compound O.C=1C(N2CCN(CCO)CC2)=NC(C)=NC=1NC(S1)=NC=C1C(=O)NC1=C(C)C=CC=C1S WXHLLJAMBQLULT-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 241000237515 Chlamys nipponensis Species 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 235000009161 Espostoa lanata Nutrition 0.000 description 1
- 240000001624 Espostoa lanata Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 241001147138 Mytilus galloprovincialis Species 0.000 description 1
- 108010087230 Sincalide Proteins 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 238000010609 cell counting kit-8 assay Methods 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 238000012650 click reaction Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000010429 evolutionary process Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000834 fixative Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 210000002064 heart cell Anatomy 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000010921 in-depth analysis Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 101150044508 key gene Proteins 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000001418 larval effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000012758 nuclear staining Methods 0.000 description 1
- 230000008823 permeabilization Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 210000000557 podocyte Anatomy 0.000 description 1
- 239000011535 reaction buffer Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000012192 staining solution Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
- C12N2500/33—Amino acids other than alpha-amino carboxylic acids, e.g. beta-amino acids, taurine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
技术领域Technical Field
本发明属于海洋生物细胞系的培养基技术领域,尤其是涉及一种虾夷扇贝血淋巴细胞培养基及其应用。The invention belongs to the technical field of culture medium of marine biological cell lines, and in particular relates to a culture medium of hemolymph cells of scallops and an application thereof.
背景技术Background Art
近年来,高通量测序技术的突破和和快速发展极大地推动了生命科学领域的研究,使得科学家们能够更快速、更精确的解读基因密码,为关键基因表达调控机制解析等研究提供基础。目前,基因表达调控研究主要依赖于模式动物平台和体外细胞系研究平台,但在进化过程中占据关键节点的非模式动物(例如海洋冠轮动物类群)的相关基础研究信息仍然缺乏。In recent years, the breakthrough and rapid development of high-throughput sequencing technology have greatly promoted research in the field of life sciences, enabling scientists to read genetic codes more quickly and accurately, and providing a basis for the analysis of key gene expression regulation mechanisms. At present, research on gene expression regulation mainly relies on model animal platforms and in vitro cell line research platforms, but there is still a lack of relevant basic research information on non-model animals (such as marine crown wheel groups) that occupy key nodes in the evolutionary process.
软体动物,俗称贝类,是动物界第二大门类,也是最大的海洋冠轮动物类群,现存种类超过100,000种。近年来,高通量测序技术的快速发展为贝类提供了破解不同谱系基因组的契机。如Wang等(2017)通过对虾夷扇贝(Patinopecten yessoensis)基因组的深度解析揭示了贝类具有古老的染色体核型,其独特的进化地位可为理解动物细胞早期起源和调控机制提供关键线索。Molluscs, commonly known as shellfish, are the second largest category in the animal kingdom and the largest group of marine crown-wheel animals, with more than 100,000 existing species. In recent years, the rapid development of high-throughput sequencing technology has provided shellfish with an opportunity to decipher the genomes of different lineages. For example, Wang et al. (2017) revealed that shellfish have ancient chromosome karyotypes through in-depth analysis of the genome of Patinopecten yessoensis , and their unique evolutionary status can provide key clues for understanding the early origin and regulatory mechanisms of animal cells.
目前,贝类软体动物中尚未建立完善的模式动物基因功能研究平台,这使得体外细胞基因功能研究平台尤为重要。前期研究中,贝类软体动物的细胞体外培养多数采用哺乳动物或者其他昆虫类动物的培养基,同时辅以自体血清作为细胞营养添加剂。其中,以L-15培养基的培养效果最好,应用也最广泛。Takeuchi等(1999)在补充有20% FBS的L-15培养基中培养地中海贻贝的足细胞;Odintsova等(2010)用2% FBS、1.75mg/L维生素E和50mg/L胰岛素作为L-15基础培养基的添加剂培养贻贝的幼虫细胞;Yoon等(2022)通过在L-15中添加盐离子和胎牛血清实现体外短期培养扇贝心脏细胞和血细胞等;Bai等(2023)在淡水贻贝的外套膜培养中发现通过添加贻贝自体血清可促进细胞的生长等。然而,大量的实验表明,贝类细胞在体外仅能维持存活而无增殖能力,且模式动物研究中表明添加血清会促进细胞的分化,从而导致细胞增殖能力下降。这阻碍了对细胞周期,细胞增殖等关键信号通路和调控模块的研究。因此,如何在无血清添加的条件下提高贝类细胞的增殖能力成为贝类细胞培养中的研究重点。At present, a complete model animal gene function research platform has not been established in shellfish mollusks, which makes the in vitro cell gene function research platform particularly important. In previous studies, most of the in vitro cell cultures of shellfish mollusks used mammalian or other insect culture media, supplemented with autologous serum as a cell nutrient additive. Among them, L-15 culture medium has the best culture effect and is the most widely used. Takeuchi et al. (1999) cultured the podocytes of Mediterranean mussels in L-15 culture medium supplemented with 20% FBS; Odintsova et al. (2010) used 2% FBS, 1.75 mg/L vitamin E and 50 mg/L insulin as additives to L-15 basal culture medium to culture mussel larval cells; Yoon et al. (2022) achieved short-term in vitro culture of scallop heart cells and blood cells by adding salt ions and fetal bovine serum to L-15; Bai et al. (2023) found that adding mussel autologous serum to the mantle culture of freshwater mussels can promote cell growth. However, a large number of experiments have shown that shellfish cells can only maintain survival in vitro without proliferation ability, and model animal studies have shown that the addition of serum will promote cell differentiation, resulting in a decrease in cell proliferation ability. This has hindered the study of key signaling pathways and regulatory modules such as cell cycle and cell proliferation. Therefore, how to improve the proliferation ability of shellfish cells under serum-free conditions has become a research focus in shellfish cell culture.
发明内容Summary of the invention
本发明提供了一种虾夷扇贝血淋巴细胞培养基及应用,所提供的培养基能够更好地维持虾夷扇贝血淋巴细胞在体外的存活和生长,从而解决了体外培养虾夷扇贝血淋巴细胞的问题,为建立软体动物细胞系提供基础。The invention provides a scallop hemolymph cell culture medium and application thereof. The provided culture medium can better maintain the survival and growth of the scallop hemolymph cells in vitro, thereby solving the problem of culturing the scallop hemolymph cells in vitro and providing a basis for establishing a mollusk cell line.
本发明所提供的虾夷扇贝血淋巴细胞培养基,是添加有盐离子、赖氨酸、脯氨酸、牛磺酸的L-15培养基;The scallop blood lymphocyte culture medium provided by the present invention is an L-15 culture medium added with salt ions, lysine, proline and taurine;
更进一步的,所述的赖氨酸的添加浓度为0.258g/L;脯氨酸的添加浓度为0.234g/L;牛磺酸的添加浓度为0.1g/L;Furthermore, the concentration of lysine added is 0.258 g/L; the concentration of proline added is 0.234 g/L; the concentration of taurine added is 0.1 g/L;
作为实施例的具体记载,所述的盐离子的组分及添加浓度如下: 2g/L NaCl、0.3g/L KCl、1.2g/L CaCl2、2.76g/L MgSO4、3g/L MgCl2、0.19g/L Na2HPO4、0.06g/LKH2PO4。As a specific record of the embodiment, the components and added concentrations of the salt ions are as follows: 2g/L NaCl, 0.3g/L KCl, 1.2g/L CaCl 2 , 2.76g/L MgSO 4 , 3g/L MgCl 2 , 0.19g/L Na 2 HPO 4 , 0.06g/L KH 2 PO 4 .
更进一步的,所述的培养基中还添加有抗生素;Furthermore, antibiotics are added to the culture medium;
作为实施例的一种具体记载,所述的抗生素的种类及添加浓度如下:青霉素60mg/L,链霉素100mg/L,庆大霉素40mg/L;As a specific record of the embodiment, the types and added concentrations of the antibiotics are as follows: penicillin 60 mg/L, streptomycin 100 mg/L, gentamicin 40 mg/L;
更进一步的,所述的培养基中还添加有pH缓冲剂,Furthermore, a pH buffer is added to the culture medium.
作为实施例的一种具体记载,所述的pH缓冲剂为HEPES。As a specific description of the embodiment, the pH buffer is HEPES.
所述的培养基的pH为7.1,渗透压均为900~1100 mOsm/kg。The pH of the culture medium is 7.1, and the osmotic pressure is 900-1100 mOsm/kg.
本发明所提供的培养基可以用于培养虾夷扇贝血淋巴细胞。The culture medium provided by the present invention can be used for culturing hemolymphocytes of the scallop.
与现有技术相比,本发明具有以下技术效果:Compared with the prior art, the present invention has the following technical effects:
(1)本发明提供了一种虾夷扇贝血淋巴细胞培养基,该培养基可用于血细胞的体外培养,扇贝血淋巴细胞在接种12h内能够快速迁移,形成60%-80%汇合度的细胞单层,并能够更好的维持体外培养细胞的存活和生长;(1) The present invention provides a scallop blood lymphocyte culture medium, which can be used for in vitro culture of blood cells. Scallop blood lymphocytes can migrate rapidly within 12 hours of inoculation to form a cell monolayer with a confluence of 60%-80%, and can better maintain the survival and growth of cells cultured in vitro;
(2)本发明中的培养基中加入了部分盐离子和部分扇贝血清游离氨基酸混合物,使用该培养基培养的扇贝细胞突破了细胞有丝分裂停滞期,出现部分增殖潜能。(2) The culture medium of the present invention contains some salt ions and some scallop serum free amino acid mixture. The scallop cells cultured with the culture medium break through the cell mitotic arrest phase and show some proliferation potential.
(3)本发明还提供了一种扇贝细胞培养基在培养扇贝血淋巴细胞中的应用方法,该方法操作简单,且培养的扇贝血淋巴细胞细胞密度大,形态好,贴壁性高。(3) The present invention also provides a method for using a scallop cell culture medium in culturing scallop blood lymphocytes. The method is simple to operate, and the cultured scallop blood lymphocytes have a high cell density, good morphology, and high wall adhesion.
附图说明BRIEF DESCRIPTION OF THE DRAWINGS
图1:基于虾夷血清游离氨基酸的3种虾夷细胞基础培养基与L-15培养基的培养效果比较照片图:其中PYM-1、PYM-2、PYM-3分别表示用NaCl调节渗透压的培养基、添加NaCl及其他盐离子调节渗透压的培养基和添加NaCl及其他盐离子调节渗透压和添加额外的营养成分的培养基。Figure 1: Photographs comparing the culture effects of three basic culture media for Yezo cells based on free amino acids from Yezo serum and L-15 culture medium: PYM-1, PYM-2, and PYM-3 represent culture media with osmotic pressure adjusted by NaCl, culture media with osmotic pressure adjusted by adding NaCl and other salt ions, and culture media with osmotic pressure adjusted by adding NaCl and other salt ions and additional nutrients, respectively.
图2:商业化L-15基础培养基、PYM-1、PYM-2、PYM-3培养扇贝血淋巴细胞的细胞贴壁率柱状图,显著性差异p<0.05。Figure 2: Bar graph of cell adhesion rate of scallop blood lymphocytes cultured in commercial L-15 basal medium, PYM-1, PYM-2, and PYM-3, with significant differences p<0.05.
图3:商业化L-15基础培养基、PYM-1、PYM-2、PYM-3培养扇贝血淋巴细胞的细胞活死染色图及显著差异性分析图,p<0.05。Figure 3: Cell live-death staining and significant difference analysis of scallop blood lymphocytes cultured in commercial L-15 basal medium, PYM-1, PYM-2, and PYM-3, p<0.05.
图4:所优化最适培养基与商业化L-15培养基培养扇贝血淋巴细胞培养7天后的的细胞增殖结果示意图。Figure 4: Schematic diagram of the cell proliferation results of scallop blood lymphocytes cultured in the optimized optimal culture medium and commercial L-15 culture medium after 7 days of culture.
具体实施方式DETAILED DESCRIPTION
本发明在分析虾夷扇贝血清的游离氨基酸组成成分的基础上,以L-15作为基础培养基,通过添加额外的盐离子和营养物质成分,建立了虾夷扇贝适用的细胞体外培养无血清优化培养基,为建立软体动物体外细胞操纵平台的建立及关键基因功能调控研究建立基础。The present invention, based on the analysis of free amino acid components of the serum of the Yesso scallop, uses L-15 as a basic culture medium and adds additional salt ions and nutrient components to establish a serum-free optimized culture medium for in vitro cell culture suitable for the Yesso scallop, thereby laying a foundation for establishing an in vitro cell manipulation platform for molluscs and studying the function regulation of key genes.
本发明的实施例中使用的虾夷扇贝血淋巴细胞,其制备方法如下:The preparation method of the hemolymphocytes of the scallop used in the embodiments of the present invention is as follows:
取1mL一次性注射器,吸取0.1mL抗凝剂,然后从消毒的虾夷横纹肌部轻轻刺入血腔,匀速抽取虾夷扇贝血淋巴;上下轻微晃动注射器保证抗凝剂和血淋巴混合均匀,以防血液凝固;卸下注射器针头,将虾夷扇贝血淋巴细胞用40μm滤膜过滤,转移至15mL离心管中;800×g离心5min;弃上清,加入L-15基础培养基制成细胞悬液。Take a 1mL disposable syringe, draw 0.1mL of anticoagulant, then gently pierce the blood cavity from the disinfected striated muscle of the Yesso scallop, and extract the hemolymph of the Yesso scallop at a uniform speed; shake the syringe slightly up and down to ensure that the anticoagulant and hemolymph are evenly mixed to prevent blood coagulation; remove the syringe needle, filter the Yesso scallop hemolymph cells with a 40μm filter membrane, and transfer them to a 15mL centrifuge tube; centrifuge at 800×g for 5min; discard the supernatant, and add L-15 basal culture medium to make a cell suspension.
其中,抗凝剂的配制方法如下:30nmol/L PBS磷酸盐缓冲液、1.5%EDTA、2.5%NaCl,充分溶解后,过滤除菌,然后保存于4℃。The preparation method of the anticoagulant is as follows: 30 nmol/L PBS phosphate buffer, 1.5% EDTA, 2.5% NaCl. After fully dissolved, filter and sterilize, and then store at 4°C.
但本发明还可以采用其它现有方法来制备虾夷扇贝血淋巴细胞。However, the present invention can also adopt other existing methods to prepare the hemolymph cells of the scallop.
下面结合实施例和附图对本发明作进一步的描述。The present invention will be further described below in conjunction with embodiments and drawings.
实施例1:虾夷扇贝血清中游离氨基酸种类和含量以及渗透压和pH的测定Example 1: Determination of free amino acid types and contents, osmotic pressure and pH in scallop serum
将过滤后的海水煮沸,置于养殖框内冷却至10℃,充气泵持续充气暂养虾夷扇贝24h。实验时,将虾夷扇贝贝壳表面用75%酒精擦拭干净,撬开扇贝贝壳,将体腔内海水及其余杂质清理干净,用浸泡了碘伏溶液的棉球擦拭扇贝肉柱横纹肌,进行消毒处理。The filtered seawater was boiled, placed in a culture frame and cooled to 10°C, and the air pump was used to continuously inflate the scallops for 24 hours. During the experiment, the shell surface of the scallops was wiped clean with 75% alcohol, the scallop shells were pried open, the seawater and other impurities in the body cavity were cleaned, and the scallop column striated muscle was wiped with a cotton ball soaked in iodine solution for disinfection.
首先制备扇贝血清,利用渗透压仪和pH计分别测定扇贝血清的渗透压和pH值,利用氨基酸分析仪测定血清中的游离氨基酸种类和含量,根据测定结果设计扇贝优化培养基的营养添加成分,并通过调整培养基的渗透压和pH使其更适宜虾夷扇贝细胞的生长。Firstly, scallop serum was prepared, and the osmotic pressure and pH value of the scallop serum were determined using an osmometer and a pH meter respectively. The types and contents of free amino acids in the serum were determined using an amino acid analyzer. According to the determination results, the nutritional supplements of the scallop optimized culture medium were designed, and the osmotic pressure and pH of the culture medium were adjusted to make it more suitable for the growth of Yesso scallop cells.
1)虾夷扇贝血清的制备方法如下:1) The preparation method of scallop serum is as follows:
用1mL一次性注射器从虾夷横纹肌部轻轻刺入血腔,匀速抽取虾夷扇贝血淋巴;卸下注射器针头,将虾夷扇贝血淋巴转移至15mL离心管中;在4℃冰箱中静置一小时,待其凝血后,所收集的上清即为虾夷扇贝血清。Use a 1mL disposable syringe to gently pierce the blood cavity from the striated muscle of the Yesso scallop and extract the hemolymph of the Yesso scallop at a uniform speed; remove the syringe needle and transfer the hemolymph of the Yesso scallop to a 15mL centrifuge tube; let it stand in a 4℃ refrigerator for one hour, wait for it to coagulate, and the collected supernatant is the Yesso scallop serum.
2)取部分虾夷扇贝血清,利用渗透压仪和pH计分别测定虾夷扇贝血清的渗透压和pH值,发现虾夷扇贝血清的渗透压为900~1100 mOsm/kg, pH值为7.0-7.2。2) Take some of the serum of the Yesso scallop and use an osmometer and a pH meter to measure the osmotic pressure and pH value of the serum of the Yesso scallop respectively. It was found that the osmotic pressure of the serum of the Yesso scallop was 900~1100 mOsm/kg, and the pH value was 7.0-7.2.
3)血清中的游离氨基酸的种类和含量的测定方法如下:3) The method for determining the types and contents of free amino acids in serum is as follows:
将获得的上述虾夷扇贝血清与0.25倍体积的磺基水杨酸充分混匀,与4℃冰箱中静置60min,2000×g离心15min;收集上清液,并重复离心1次;吸取上清液,并于无菌条件下用0.22μm滤膜过滤除菌,与A300氨基酸分析仪中测定虾夷扇贝血清中游离氨基酸的含量和种类。测定结果如表1所示。The obtained scallop serum was thoroughly mixed with 0.25 times the volume of sulfosalicylic acid, placed in a 4°C refrigerator for 60 minutes, and centrifuged at 2000×g for 15 minutes; the supernatant was collected and centrifuged once; the supernatant was aspirated and sterilized by filtration with a 0.22 μm filter membrane under sterile conditions, and the content and type of free amino acids in the scallop serum were determined with an A300 amino acid analyzer. The results are shown in Table 1.
其中,虾夷血清所测游离氨基酸数据中有两种游离氨基酸成分在商业化L-15中含量不足,分别是赖氨酸和脯氨酸。因此本发明拟在L-15中添加所缺失的游离氨基酸成分来对培养基进行优化,此外,本发明还添加了牛磺酸。Among them, the free amino acid data measured by the serum of the Japanese safari animal showed that the content of two free amino acid components in the commercial L-15 was insufficient, namely lysine and proline. Therefore, the present invention intends to add the missing free amino acid components to L-15 to optimize the culture medium. In addition, the present invention also adds taurine.
表1:虾夷扇贝血清中游离氨基酸及其含量分析结果表Table 1: Analysis results of free amino acids and their contents in serum of scallop
实施例2:优化虾夷扇贝血淋巴细胞基础培养基Example 2: Optimization of scallop blood lymphocyte basal culture medium
虾夷基础培养基的优化是在L-15培养基(Hyclone)的基础上,结合虾夷血清中的游离氨基酸的种类组成及含量(表1)、最适渗透压和pH等测定结果,设计和配制优化培养基(PYM),比较它们支持虾夷血淋巴细生长和生存能力。The optimization of the basic culture medium for Yezo was based on L-15 culture medium (Hyclone). Combined with the types, composition and content of free amino acids in Yezo serum (Table 1), the optimal osmotic pressure and pH, an optimized culture medium (PYM) was designed and prepared to compare their ability to support the growth and survival of Yezo hemolymph cells.
其中,编号为PYM-1的培养基是在L-15基础培养基中添加了18g/L NaCl以调节渗透压制成的培养基;PYM-2是在L-15基础培养基中添加了12g/L NaCl、0.3g/L KCl、1.2g/LCaCl2、2.76g/L MgSO4、3g/L MgCl2、0.19g/L Na2HPO4、0.06g/L KH2PO4制成的培养基;PYM-3是在PYM-2的基础上添加氨基酸组分,分别是终浓度为0.258g/L 赖氨酸,0.234g/L 脯氨酸;牛磺酸终浓度为0.1g/L;PYM1-3培养基以及L-15基础培养基均添加了青霉素-链霉素-庆大霉素抗生素和HEPES缓冲液,终浓度为:青霉素60mg/L,链霉素100mg/L,庆大霉素40mg/L;HEPES 2.38g/L,培养基的pH为7.1。上述PYM-1、PYM-2、PYM-3培养基渗透压均为900~1100mOsm/kg。Among them, the culture medium numbered PYM-1 is a culture medium prepared by adding 18g/L NaCl to L-15 basic culture medium to adjust the osmotic pressure; PYM-2 is a culture medium prepared by adding 12g/L NaCl, 0.3g/L KCl, 1.2g/LCaCl 2 , 2.76g/L MgSO 4 , 3g/L MgCl 2 , 0.19g/L Na 2 HPO 4 , and 0.06g/L KH 2 PO 4 to L-15 basic culture medium; PYM-3 is a culture medium prepared by adding amino acid components to PYM-2, with final concentrations of 0.258g/L lysine, 0.234g/L Proline; Taurine final concentration is 0.1g/L; Penicillin-Streptomycin-Gentamicin antibiotics and HEPES buffer are added to PYM1-3 medium and L-15 basal medium, with final concentrations of: Penicillin 60mg/L, Streptomycin 100mg/L, Gentomycin 40mg/L; HEPES 2.38g/L, pH of the medium is 7.1. The osmotic pressure of the above PYM-1, PYM-2, and PYM-3 medium is 900~1100mOsm/kg.
实施例3:扇贝细胞培养基在培养扇贝细胞中的应用Example 3: Application of scallop cell culture medium in culturing scallop cells
1)将虾夷扇贝表面贝壳用75%酒精擦拭干净并置于超净工作台中紫外灭菌30min;1) Wipe the surface of the scallop shells with 75% alcohol and place them in a clean bench for UV sterilization for 30 minutes;
2)使用1mL的一次性无菌注射器从虾夷扇贝肉柱中抽取2-3mL的血淋巴;2) Use a 1 mL disposable sterile syringe to extract 2-3 mL of hemolymph from the scallop column;
3)将步骤2)中取得的血淋巴用40μm滤膜进行过滤;3) Filter the hemolymph obtained in step 2) using a 40 μm filter membrane;
4)将步骤3)中过滤的血淋巴细胞以800r/min离心5min,并弃去上层血清;4) Centrifuge the blood lymphocytes filtered in step 3) at 800 rpm for 5 min, and discard the upper serum;
5)分别使用加入青霉素-链霉素-庆大霉素抗生素的L-15、PYM-1、PYM-2、PYM_3基础培养基重悬虾夷扇贝血淋巴细胞(稀释浓度为1.5×105/mL),并接种在96孔板中培养,培养条件:O2含量为5%,温度为20℃,无需额外的CO2和湿度条件,静置培养,根据细胞生长状态适当换液。5) Use L-15, PYM-1, PYM-2, and PYM_3 basal culture media with penicillin-streptomycin-gentamicin antibiotics to resuspend the blood lymphocytes of the Japanese scallop (dilution concentration is 1.5×10 5 /mL), and inoculate them into 96-well plates for culture. The culture conditions are: O 2 content is 5%, temperature is 20℃, no additional CO 2 and humidity conditions are required, and static culture is carried out. Change the medium appropriately according to the cell growth status.
分别观察实施例3中L-15、PYM-1、PYM-2、PYM-3细胞培养1Day、3Day、7Day后的扇贝血淋巴细胞的生长状态。The growth status of scallop blood lymphocytes after culturing L-15, PYM-1, PYM-2, and PYM-3 cells in Example 3 for 1 Day, 3 Days, and 7 Days were observed respectively.
实施例4:培养基的培养效果Example 4: Culture effect of culture medium
1、通过细胞粘附实验检测实施例3中虾夷扇贝血淋巴细胞培养3天后的贴壁率1. The cell adhesion test was used to detect the adhesion rate of the hemolymph cells of the scallop in Example 3 after 3 days of culture.
将实施例3中的细胞培养72h后,弃除培养基,用3×PBS润洗3遍,重新加入新的培养基,并在每孔中加入100μL CCK-8(Beyotime)溶液,置于培养箱中培养3h后,用酶标仪测量吸光度。After culturing the cells in Example 3 for 72 hours, the culture medium was discarded, the cells were rinsed three times with 3×PBS, new culture medium was added, and 100 μL of CCK-8 (Beyotime) solution was added to each well. After culturing in an incubator for 3 hours, the absorbance was measured with a microplate reader.
2、通过Calcein-AM/PI染色法检测实施例3中虾夷扇贝血淋巴细胞的活性,具体步骤如下:2. The activity of hemolymphocytes of the scallops in Example 3 was detected by Calcein-AM/PI staining, and the specific steps were as follows:
首先用3×PBS将1mM的Calcein-AM原液稀释成1μM的Calcein-AM工作液;弃去孔板中的培养基,加入3×PBS溶液,轻轻摇晃后弃去;然后将200μL配制好的Calcein-AM溶液加入到24孔板中,将细胞转移至20℃培养箱中孵育细胞30min;之后用3×PBS将5mM的PI原液稀释成5μM,加入细胞中,避光孵育5min后用3×PBS溶液洗涤细胞2次,用倒置荧光显微镜观察并拍照。First, 1mM Calcein-AM stock solution was diluted into 1μM Calcein-AM working solution with 3×PBS; the culture medium in the well plate was discarded, 3×PBS solution was added, and it was gently shaken and discarded; then 200μL of the prepared Calcein-AM solution was added to the 24-well plate, and the cells were transferred to a 20℃ incubator and incubated for 30min; then 5mM PI stock solution was diluted into 5μM with 3×PBS, added to the cells, incubated in the dark for 5min, and then washed twice with 3×PBS solution, and observed and photographed with an inverted fluorescence microscope.
3、通过EdU染色法检测实施例3中扇贝血淋巴细胞的增殖能力,具体方法如下:3. The proliferation capacity of scallop hemolymphocytes in Example 3 was detected by EdU staining, and the specific method is as follows:
⑴标记虾夷扇贝血淋巴细胞⑴ Labeling of blood lymphocytes of scallop
实施例3的细胞培养过夜稳定状态后,用PYM-3培养基和L-15培养基(含抗生素)将EdU原液(10mM)稀释,制备2×EdU工作溶 液(10μM),随后放入20℃的水浴锅中预热。更换24孔细胞培养板中的培养基(250μL/孔),然后等体积加入250μL2×EdU工作液,混匀,于20℃培养箱中孵育2天。After the cells of Example 3 were cultured overnight to a stable state, the EdU stock solution (10 mM) was diluted with PYM-3 medium and L-15 medium (containing antibiotics) to prepare a 2×EdU working solution (10 μM), which was then preheated in a 20°C water bath. The culture medium in the 24-well cell culture plate (250 μL/well) was replaced, and then 250 μL of 2×EdU working solution was added in an equal volume, mixed, and incubated in a 20°C incubator for 2 days.
⑵固定和透化细胞⑵Fix and permeabilize cells
细胞经过上述孵育后,吸出培养基,向24孔板中加入200μL含4%甲醛的3×PBS溶液,室温避光孵育15min,吸出固定液。用洗涤液(含3%牛血清蛋白的3×PBS溶液)洗涤细胞2次。吸出洗涤液,向每个孔中加入500μL通透液(每100mL3×PBS溶液中加入0.5mL的TritonX-100),通透20min。去除上述添加液后,至少洗涤两次。After the cells have been incubated as above, the culture medium is aspirated, and 200 μL of 3×PBS solution containing 4% formaldehyde is added to the 24-well plate. Incubate at room temperature in the dark for 15 minutes, and aspirate the fixative. Wash the cells twice with washing solution (3×PBS solution containing 3% bovine serum albumin). Aspirate the washing solution, add 500 μL of permeabilization solution (0.5 mL of TritonX-100 per 100 mL of 3×PBS solution) to each well, and permeabilize for 20 minutes. After removing the above-mentioned additives, wash at least twice.
⑶Edu结合液孵育(3) Incubation with Edu binding solution
首先配制EdU结合液(每孔含430μLClick Reaction Buffer,20μLCuSO4,1μLAzide488,50μLClick Additive Solution),结合液要现配现用,加入结合液后轻轻摇动孔板以确保结合液均匀分布,室温条件下避光孵育30min。然后除去EdU结合液,用洗涤液洗涤细胞单层2次,每次5min。First, prepare the EdU binding solution (430 μL Click Reaction Buffer, 20 μL CuSO 4 , 1 μL Zie 488, 50 μL Click Additive Solution per well). The binding solution should be prepared and used immediately. After adding the binding solution, gently shake the plate to ensure that the binding solution is evenly distributed. Incubate at room temperature in the dark for 30 minutes. Then remove the EdU binding solution and wash the cell monolayer twice with washing solution, 5 minutes each time.
⑷细胞核染色⑷ Nuclear staining
首先按照Hoechst33258:3×PBS=1μL:1mL的比例稀释染色液。然后向细胞培养孔中加入500μL稀释后的Hoechst33258溶液,盖上锡箔纸,在室温下避光孵育10min后,吸出Hoechst33258溶液。最后用3×PBS洗涤细胞三次,每次5min,吸出3×PBS溶液。用LSM900共聚焦显微镜拍照并记录。First, dilute the staining solution according to the ratio of Hoechst33258:3×PBS=1μL:1mL. Then add 500μL of the diluted Hoechst33258 solution to the cell culture well, cover with tin foil, incubate at room temperature in the dark for 10 minutes, and then aspirate the Hoechst33258 solution. Finally, wash the cells three times with 3×PBS, each time for 5 minutes, and aspirate the 3×PBS solution. Take pictures and record with LSM900 confocal microscope.
如图1所示,L-15和新的三种PYM基础培养基均能支持虾夷扇贝血淋巴细胞在细胞培养板中的附着和存活,在接种24h后,三种PYM基础培养基的血淋巴细胞生长状态相似,都能附着在细胞板上,但PYM-3附着率明显要高于PYM-1和PYM-2,并且PYM-3能够形成连续的细胞单层;L-15基础培养基中的虾夷扇贝血淋巴细胞未附着在细胞板上;并且死细胞成漂浮状聚集成团,接种72h后,PYM-1细胞开始脱落,PYM-2出现聚集情况,PYM-3细胞无聚集,无明显收缩现象;接种7d后,L-15基础培养基、PYM-1、PYM-2中细胞出现大范围破裂死亡,PYM-3中虾夷扇贝血淋巴细胞在体外生长和存活效果最好。与其他培养基相比,该培养基中的细胞更健康,细胞单层致密且细胞碎片少。这表明PYM-3能够更好的维持体外培养扇贝血淋巴细胞的存活和生长。As shown in Figure 1, L-15 and the three new PYM basal mediums can support the attachment and survival of the blood lymphocytes of the scallop in the cell culture plate. After 24 hours of inoculation, the growth state of the blood lymphocytes in the three PYM basal mediums is similar and can all attach to the cell plate, but the attachment rate of PYM-3 is significantly higher than that of PYM-1 and PYM-2, and PYM-3 can form a continuous cell monolayer; the blood lymphocytes of the scallop in the L-15 basal medium did not attach to the cell plate; and the dead cells aggregated in a floating state. After 72 hours of inoculation, the PYM-1 cells began to fall off, the PYM-2 cells aggregated, and the PYM-3 cells did not aggregate and had no obvious shrinkage phenomenon; after 7 days of inoculation, the cells in the L-15 basal medium, PYM-1, and PYM-2 showed large-scale rupture and death, and the blood lymphocytes of the scallop in PYM-3 had the best in vitro growth and survival. Compared with other culture media, the cells in this culture medium are healthier, the cell monolayer is dense, and there are fewer cell fragments. This indicates that PYM-3 can better maintain the survival and growth of scallop blood lymphocytes cultured in vitro.
如图2所示,L-15培养3Day后细胞的平均贴比率在17%左右,PYM-1细胞贴壁率在20%左右,PYM-2培养后细胞贴壁率在45%左右,而PYM-3培养后的细胞贴壁率达到75%左右,优化后的PYM-3细胞贴壁率有大幅提升。As shown in Figure 2, after 3 days of L-15 culture, the average cell adhesion rate was about 17%, the PYM-1 cell adhesion rate was about 20%, the PYM-2 cell adhesion rate was about 45%, and the PYM-3 cell adhesion rate reached about 75% after culture. The optimized PYM-3 cell adhesion rate was greatly improved.
如图3所示,PYM-3培养基与L-15、PYM-1、PYM-2相比,死细胞数量大幅度减少,这说明使用本申请发明的扇贝细胞培养基PYM-3能够更好地在体外培养扇贝血淋巴细胞,使细胞能够在体外更好地存活和生长,荧光统计信号也说明PYM-3单位面积内死细胞荧光信号强度显著下降,活细胞荧光信号强度显著上升,表明PYM-3培养基培养的细胞状态最佳。As shown in Figure 3, compared with L-15, PYM-1, and PYM-2, the number of dead cells in PYM-3 medium is greatly reduced, which shows that the scallop cell culture medium PYM-3 of the present invention can better culture scallop blood lymphocytes in vitro, so that the cells can survive and grow better in vitro. The fluorescent statistical signal also shows that the fluorescence signal intensity of dead cells per unit area of PYM-3 is significantly decreased, and the fluorescence signal intensity of live cells is significantly increased, indicating that the cells cultured in PYM-3 medium are in the best state.
如图4所示,Edu染色结果表明,PYM-3与L-15培养基相比,培养的扇贝血淋巴细胞能够打破扇贝血淋巴细胞的有丝分裂停滞期,部分细胞出现增殖现象。As shown in Figure 4, the Edu staining results showed that compared with L-15 medium, scallop blood lymphocytes cultured in PYM-3 were able to break the mitotic arrest phase of scallop blood lymphocytes, and some cells showed proliferation.
以上所述,仅是本发明的较佳实施例,并非对本发明作任何限制,凡是根据本发明技术实质对以上实施例所作的任何简单修改、变更以及等效变换,均仍属于本发明技术方案的保护范围。The above description is only a preferred embodiment of the present invention and does not limit the present invention in any way. Any simple modification, change and equivalent transformation made to the above embodiment based on the technical essence of the present invention still falls within the protection scope of the technical solution of the present invention.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202411024828.0A CN118546878B (en) | 2024-07-29 | 2024-07-29 | A serum-free culture medium for in vitro culture of hemolymphocytes of scallop |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202411024828.0A CN118546878B (en) | 2024-07-29 | 2024-07-29 | A serum-free culture medium for in vitro culture of hemolymphocytes of scallop |
Publications (2)
Publication Number | Publication Date |
---|---|
CN118546878A CN118546878A (en) | 2024-08-27 |
CN118546878B true CN118546878B (en) | 2024-10-18 |
Family
ID=92455243
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202411024828.0A Active CN118546878B (en) | 2024-07-29 | 2024-07-29 | A serum-free culture medium for in vitro culture of hemolymphocytes of scallop |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN118546878B (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102965331A (en) * | 2012-11-16 | 2013-03-13 | 中国海洋大学 | Method for culturing chlamys farreri trochophore cell line |
CN105483075A (en) * | 2015-11-19 | 2016-04-13 | 中国海洋大学 | Culture medium and method for culturing urechis unicinctus trochophore cell line |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023086502A1 (en) * | 2021-11-12 | 2023-05-19 | Virginia Tech Intellectual Properties, Inc. | Hydrolyzed protein serum replacement compositions |
-
2024
- 2024-07-29 CN CN202411024828.0A patent/CN118546878B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102965331A (en) * | 2012-11-16 | 2013-03-13 | 中国海洋大学 | Method for culturing chlamys farreri trochophore cell line |
CN105483075A (en) * | 2015-11-19 | 2016-04-13 | 中国海洋大学 | Culture medium and method for culturing urechis unicinctus trochophore cell line |
Also Published As
Publication number | Publication date |
---|---|
CN118546878A (en) | 2024-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102304492B (en) | Primary culture method of crucian carp hepatocytes | |
Han et al. | Improved primary cell culture and subculture of lymphoid organs of the greasyback shrimp Metapenaeus ensis | |
CN105462884B (en) | The isolation and purification method of mycoplasma anatis culture medium and mycoplasma anatis | |
CN105505863A (en) | Culture method for heterocephalus glaber cardiac muscle cell | |
CN114621913A (en) | Method for establishing liver cell line of rainbow trout | |
CN118546878B (en) | A serum-free culture medium for in vitro culture of hemolymphocytes of scallop | |
CN107129962B (en) | A kind of primary culture method of Hirudo japonica salivary gland cell | |
CN109971700A (en) | A method for culturing primary gill cells of pufferfish with dark stripes | |
CN111690613B (en) | Tilapia gilvata brain nerve cell line, transfection method, culture method and application thereof | |
CN101451121B (en) | Construction method of Epinephelus fuscoguttatus heart cell line | |
Moritomo et al. | Cell culture of clonal ginbuna crucian carp hematopoietic cells: differentiation of cultured cells into erythrocytes in vivo | |
CN104059876B (en) | A kind of cultural method improving chicken Skeletal Muscle Cell oxidative metabolism ability | |
CN110713969A (en) | A kind of method for culturing blue crab blood cells by grouping | |
CN110872573B (en) | Novel method for separating and culturing primary cardiomyocytes of zebra fish | |
CN111088313B (en) | Reagent for rapidly fixing cell count of tetrahymena thermophila and counting method thereof | |
CN106635891A (en) | Special rapid mycoplasmabovis culture medium and mycoplasmabovis separation and purification method | |
CN102409021A (en) | Establishment of Jinhua pig fibroblast cell line and its culture method | |
CN101451122A (en) | Construction method of Epinephelus fuscoguttatus swim bladder cell line | |
CN114874974A (en) | Epinephelus coioides intestinal cell line ECGI-21 and application thereof | |
CN108034691A (en) | A kind of method of the abundance of microorganism in accurate counting invertebrate hemolymph | |
CN1274815C (en) | Neurocyte extract and its uses in mesenchyma stem cell differentiation induction | |
CN103122333A (en) | Method for separation, purification, culture and passage of gill epithelial cells of hybridized prussian carp | |
CN1250713C (en) | Method for digesting blood smooth muscle | |
Guo et al. | Long-term in-vitro culture and subculture of the hemocytes of swimming crab Portunus trituberculatus | |
CN115444853B (en) | A method for preventing and treating pathogenic ciliates in aquatic animals |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |